BR9605417A - Sulfonimidamidas substituídas processos para a sua preparação seu emprego como medicamento ou diagnóstico bem como o medicamento contendo as mesmas - Google Patents

Sulfonimidamidas substituídas processos para a sua preparação seu emprego como medicamento ou diagnóstico bem como o medicamento contendo as mesmas

Info

Publication number: BR9605417A
Authority: BR; Brazil
Prior art keywords: medicine; sulfonimidamides; diagnosis; preparation; well
Prior art date: 1995-11-03

Application number

BR9605417A

Other languages

English (en)

Inventor

Andreas Weichert

Wolfgang Scholz

Udo Albus

Hans Jochen Lang

Heinz-Werner Kleemann

Joachin Brendel

Jan-Robert Schwark

Original Assignee

Hoechst Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-11-03

Filing date

1996-11-04

Publication date

1998-08-04

1996-11-04 Application filed by Hoechst Ag filed Critical Hoechst Ag

1998-08-04 Publication of BR9605417A publication Critical patent/BR9605417A/pt

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C381/00—Compounds containing carbon and sulfur and having functional groups not covered by groups C07C301/00 - C07C337/00
- C07C381/10—Compounds containing sulfur atoms doubly-bound to nitrogen atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Urology & Nephrology (AREA)
Diabetes (AREA)
Endocrinology (AREA)
Hematology (AREA)
Hospice & Palliative Care (AREA)
Emergency Medicine (AREA)
Vascular Medicine (AREA)
Surgery (AREA)
Obesity (AREA)
Gastroenterology & Hepatology (AREA)
Pulmonology (AREA)
Reproductive Health (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

BR9605417A 1995-11-03 1996-11-04 Sulfonimidamidas substituídas processos para a sua preparação seu emprego como medicamento ou diagnóstico bem como o medicamento contendo as mesmas BR9605417A (pt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE19540995A DE19540995A1 (de)	1995-11-03	1995-11-03	Substituierte Sulfonimidamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament

Publications (1)

Publication Number	Publication Date
BR9605417A true BR9605417A (pt)	1998-08-04

Family

ID=7776535

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BR9605417A BR9605417A (pt)	1995-11-03	1996-11-04	Sulfonimidamidas substituídas processos para a sua preparação seu emprego como medicamento ou diagnóstico bem como o medicamento contendo as mesmas

Country Status (30)

Country	Link
US (1)	US5708034A (pt)
EP (1)	EP0771788B1 (pt)
JP (1)	JP3924028B2 (pt)
KR (1)	KR970025611A (pt)
CN (1)	CN1069312C (pt)
AR (1)	AR004253A1 (pt)
AT (1)	ATE188688T1 (pt)
AU (1)	AU707256B2 (pt)
BR (1)	BR9605417A (pt)
CA (1)	CA2189221C (pt)
CZ (1)	CZ290811B6 (pt)
DE (2)	DE19540995A1 (pt)
DK (1)	DK0771788T3 (pt)
ES (1)	ES2143122T3 (pt)
GR (1)	GR3032689T3 (pt)
HR (1)	HRP960496B1 (pt)
HU (1)	HUP9603023A3 (pt)
IL (1)	IL119552A (pt)
MX (1)	MX9605317A (pt)
MY (1)	MY132862A (pt)
NO (1)	NO306550B1 (pt)
NZ (1)	NZ299682A (pt)
PL (1)	PL184570B1 (pt)
PT (1)	PT771788E (pt)
RU (1)	RU2180658C2 (pt)
SI (1)	SI0771788T1 (pt)
SK (1)	SK281766B6 (pt)
TR (1)	TR199600873A2 (pt)
TW (1)	TW352382B (pt)
ZA (1)	ZA969211B (pt)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE19820064A1 (de) *	1998-05-06	1999-11-11	Hoechst Marion Roussel De Gmbh	Substituierte Sulfonylcyanamide, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament
DE19832429A1 (de) *	1998-07-18	2000-01-20	Hoechst Marion Roussel De Gmbh	Imidazolderivate mit Biphenylsulfonylsubstitution, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE19832428A1 (de) *	1998-07-18	2000-01-20	Hoechst Marion Roussel De Gmbh	Imidazolderivate mit Biphenylsulfonylsubstitution, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
SG10201608528YA (en)	2011-12-21	2016-12-29	Novira Therapeutics Inc	Hepatitis b antiviral agents
JP2015533782A (ja)	2012-08-28	2015-11-26	ヤンセン・サイエンシズ・アイルランド・ユーシー	スルファモイル−アリールアミド及びｂ型肝炎の治療のための薬剤としてのその使用
EP2961732B1 (en)	2013-02-28	2017-04-12	Janssen Sciences Ireland UC	Sulfamoyl-arylamides and the use thereof as medicaments for the treatment of hepatitis b
AU2014247138B2 (en)	2013-04-03	2018-06-28	Janssen Sciences Ireland Uc	N-phenyl-carboxamide derivatives and the use thereof as medicaments for the treatment of hepatitis B
JO3603B1 (ar)	2013-05-17	2020-07-05	Janssen Sciences Ireland Uc	مشتقات سلفامويل بيرولاميد واستخدامها كادوية لمعالجة التهاب الكبد نوع بي
CA2909742C (en)	2013-05-17	2020-08-04	Janssen Sciences Ireland Uc	Sulphamoylthiophenamide derivatives and the use thereof as medicaments for the treatment of hepatitis b
ES2774749T3 (es)	2013-07-25	2020-07-22	Janssen Sciences Ireland Unlimited Co	Derivados de pirrolamida sustituidos con glioxamida y su uso como medicamentos para el tratamiento de la hepatitis B
JP6452119B2 (ja)	2013-10-23	2019-01-16	ヤンセン・サイエンシズ・アイルランド・アンリミテッド・カンパニー	カルボキサミド誘導体およびｂ型肝炎の処置のための医薬品としてのその使用
US9169212B2 (en)	2014-01-16	2015-10-27	Novira Therapeutics, Inc.	Azepane derivatives and methods of treating hepatitis B infections
US10392349B2 (en)	2014-01-16	2019-08-27	Novira Therapeutics, Inc.	Azepane derivatives and methods of treating hepatitis B infections
KR20160128305A (ko)	2014-02-05	2016-11-07	노비라 테라퓨틱스, 인코포레이티드	Hbv 감염의 치료를 위한 병용 요법
CA2932551A1 (en)	2014-02-06	2015-08-13	Janssen Sciences Ireland Uc	Sulphamoylpyrrolamide derivatives and the use thereof as medicaments for the treatment of hepatitis b
CN107847762A (zh)	2015-03-19	2018-03-27	诺维拉治疗公司	氮杂环辛烷和氮杂环壬烷衍生物以及治疗乙型肝炎感染的方法
US10875876B2 (en)	2015-07-02	2020-12-29	Janssen Sciences Ireland Uc	Cyclized sulfamoylarylamide derivatives and the use thereof as medicaments for the treatment of hepatitis B
HK1259410A1 (zh)	2015-09-29	2019-11-29	诺维拉治疗公司	乙型肝炎抗病毒剂的晶体形式
EP3848026A1 (en)	2016-04-15	2021-07-14	Novira Therapeutics Inc.	Combinations and methods comprising a capsid assembly inhibitor
DE112018000617T5 (de) *	2017-01-31	2019-11-07	The Procter & Gamble Company	Geformte Vliesstoffe und diese enthaltende Artikel
US10577722B2 (en)	2017-06-30	2020-03-03	The Procter & Gamble Company	Method for making a shaped nonwoven
EP3644930A1 (en)	2017-06-30	2020-05-06	The Procter and Gamble Company	Shaped nonwoven
WO2019175657A1 (en)	2018-03-14	2019-09-19	Janssen Sciences Ireland Unlimited Company	Capsid assembly modulator dosing regimen
AU2019306658A1 (en)	2018-07-20	2021-01-07	F. Hoffmann-La Roche Ag	Sulfonimidamide compounds as inhibitors of interleukin-1 activity
KR20210130753A (ko)	2019-02-22	2021-11-01	얀센 사이언시즈 아일랜드 언리미티드 컴퍼니	Hbv 감염 또는 hbv-유발성 질환의 치료에 유용한 아미드 유도체
US11505884B2 (en)	2019-03-18	2022-11-22	The Procter & Gamble Company	Shaped nonwovens that exhibit high visual resolution
AR119732A1 (es)	2019-05-06	2022-01-05	Janssen Sciences Ireland Unlimited Co	Derivados de amida útiles en el tratamiento de la infección por vhb o de enfermedades inducidas por vhb
CN116492469A (zh) *	2023-05-22	2023-07-28	遵义医科大学附属医院	一种通道阻滞剂在制备治疗和/或预防肝纤维疾病药物中的应用

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3780027A (en) *	1970-04-29	1973-12-18	Merck & Co Inc	Anthranilic acid derivatives
US5140039A (en) *	1988-01-15	1992-08-18	Abbott Laboratories	Aminomethyl-thiochroman compounds
WO1989006534A1 (en) *	1988-01-15	1989-07-27	Abbott Laboratories	Aminomethyl-chroman and -thiochroman compounds
US5185364A (en) *	1988-01-15	1993-02-09	Abbott Laboratories	Aminomethyl-chroman and -thiochroman compounds
DE4010325A1 (de) *	1989-04-03	1990-10-04	Ciba Geigy Ag	Neue carbaminsaeureester
DE3929582A1 (de) *	1989-09-06	1991-03-07	Hoechst Ag	Benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament sowie sie enthaltendes medikament
US5140026A (en) *	1991-05-09	1992-08-18	A. H. Robins Company, Incorporated	N-aminoalkyl-S-aryl-S-alkyl (or substituted alkyl) sulfoximines as antiarrhythmic agents
ES2108144T3 (es) *	1992-02-15	1997-12-16	Hoechst Ag	Benzoilguanidinas sustituidas en orto, procedimiento para su preparacion, su utilizacion como medicamento o agente de diagnostico, asi como medicamento que las contiene.
CZ284456B6 (cs) *	1992-02-15	1998-12-16	Hoechst Aktiengesellschaft	Aminosubstituované benzoylguanidiny, způsob jejich přípravy, jejich použití jako léčiv a léčivo, které je obsahuje
ATE139526T1 (de) *	1992-02-15	1996-07-15	Hoechst Ag	3,5-substituierte benzoylguanidine, mit antiarrythmischer wirkung und inhibierender wirkung auf die proliferationen von zellen
DK0577024T3 (pt) *	1992-07-01	1997-02-24	Hoechst Ag
DK0580550T3 (da) *	1992-07-21	1998-02-02	Ciba Geigy Ag	Oxamidsyrederivater som hypercholesterolæmiske midler
EP0589336B1 (de) *	1992-09-22	1997-01-08	Hoechst Aktiengesellschaft	Benzoylguanidine, Verfahren zu ihrer Herstellung, sowie ihre Verwendung als Antiarrhythmika
ATE198328T1 (de) *	1992-09-28	2001-01-15	Hoechst Ag	Antiarrhythmische und cardioprotektive substituierte 1(2h)-isochinoline, verfahren zu deren herstellung, diese enthaltende arzneimittel und ihre anwendung für die herstellung eines arzneimittels zur behandlung von herzinsuffizienzen
DK0600371T3 (da) *	1992-12-02	1999-09-20	Hoechst Ag	Guanidinalkyl-1,1-bisphosphonsyrederivater, fremgangsmåde til deres fremstilling samt deres anvendelse
TW250477B (pt) *	1992-12-15	1995-07-01	Hoechst Ag
TW250479B (pt) *	1992-12-15	1995-07-01	Hoechst Ag
ATE151071T1 (de) *	1992-12-16	1997-04-15	Hoechst Ag	3,5-substituierte aminobenzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament oder diagnostikum sowie sie enthaltendes medikament
EP0604852A1 (de) *	1992-12-28	1994-07-06	Hoechst Aktiengesellschaft	2,4-Substituierte 5-(N-substituierte-Sulfamoyl)-Benzoylguanidine, als Antiarrythmika, Inhibitoren der Proliferationen von Zellen, und Inhibitoren des Natrium-Protonen-Antiporters
EP0612723B1 (de) *	1993-02-20	1997-08-27	Hoechst Aktiengesellschaft	Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, als Inhibitoren des zellulären Na+/H+-Austauschs oder als Diagnostikum sowie sie enthaltendes Medikament
DE59401361D1 (de) *	1993-02-23	1997-02-06	Hoechst Ag	Substituierte Benzolsulfonylharnstoffe und -thioharnstoffe- Verfahren zu ihrer Herstellung und ihre Verwendung als Pharmazeutika
IL109570A0 (en) *	1993-05-17	1994-08-26	Fujisawa Pharmaceutical Co	Guanidine derivatives, pharmaceutical compositions containing the same and processes for the preparation thereof
DE4318658A1 (de) *	1993-06-04	1994-12-08	Hoechst Ag	Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4318756A1 (de) *	1993-06-05	1994-12-08	Hoechst Ag	Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4325822A1 (de) *	1993-07-31	1995-02-02	Hoechst Ag	Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
EP0639573A1 (de) *	1993-08-03	1995-02-22	Hoechst Aktiengesellschaft	Benzokondensierte 5-Ringheterocyclen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, ihre Verwendung als Diagnostikum, sowie sie enthaltendes Medikament
DE4327244A1 (de) *	1993-08-13	1995-02-16	Hoechst Ag	Harnstoffsubstituierte Benzoylguandine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4328869A1 (de) *	1993-08-27	1995-03-02	Hoechst Ag	Ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4344550A1 (de) *	1993-12-24	1995-06-29	Hoechst Ag	Substituierte 1-Oxo-1,2-dihydro-isochinolinoyl- und 1,1-Dioxo-2H-1,2-benzothiazinoylguanidine, Verfahrenzu ihrer Herstellung, ihre Verwendung als Medikamentt oder Diagnostikum sowie sie enthaltendes Medikamen
TW415937B (en) *	1994-01-25	2000-12-21	Hoechst Ag	Phenyl-substituted alkylcarboxylic acid guanidides bearing perfluoroalkyl groups, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
DE4412334A1 (de) *	1994-04-11	1995-10-19	Hoechst Ag	Substituierte N-Heteroaroylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4415873A1 (de) *	1994-05-05	1995-11-09	Hoechst Ag	Substituierte bizyklische Heteroaroylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4417004A1 (de) *	1994-05-13	1995-11-16	Hoechst Ag	Perfluoralkyl-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4422685A1 (de) *	1994-06-29	1996-01-04	Hoechst Ag	Ortho-amino-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
IL114670A0 (en) *	1994-08-05	1995-11-27	Fujisawa Pharmaceutical Co	Guanidine derivatives pharmaceutical compositions containing the same and processes for the preparation thereof
DE4432105A1 (de) *	1994-09-09	1996-03-14	Hoechst Ag	Fluoro-alkyl/alkenyl-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4432106A1 (de) *	1994-09-09	1996-03-14	Hoechst Ag	Mit Heterocyclen-N-Oxid-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum, sie enthaltendes Medikament sowie Zwischenprodukte zu ihrer Herstellung
DE4432101A1 (de) *	1994-09-09	1996-03-14	Hoechst Ag	Aminosäure-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4441880A1 (de) *	1994-11-24	1996-05-30	Hoechst Ag	Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE59603311D1 (de) *	1995-01-30	1999-11-18	Hoechst Ag	Basisch-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament

1995
- 1995-11-03 DE DE19540995A patent/DE19540995A1/de not_active Withdrawn
1996
- 1996-10-08 PL PL96316440A patent/PL184570B1/pl unknown
- 1996-10-22 ES ES96116938T patent/ES2143122T3/es not_active Expired - Lifetime
- 1996-10-22 DK DK96116938T patent/DK0771788T3/da active
- 1996-10-22 SI SI9630136T patent/SI0771788T1/xx unknown
- 1996-10-22 EP EP96116938A patent/EP0771788B1/de not_active Expired - Lifetime
- 1996-10-22 AT AT96116938T patent/ATE188688T1/de not_active IP Right Cessation
- 1996-10-22 PT PT96116938T patent/PT771788E/pt unknown
- 1996-10-22 DE DE59604165T patent/DE59604165D1/de not_active Expired - Lifetime
- 1996-10-28 HR HR960496A patent/HRP960496B1/xx not_active IP Right Cessation
- 1996-10-30 CZ CZ19963184A patent/CZ290811B6/cs not_active IP Right Cessation
- 1996-10-30 TW TW085113224A patent/TW352382B/zh active
- 1996-10-30 CA CA002189221A patent/CA2189221C/en not_active Expired - Fee Related
- 1996-10-30 CN CN96122091A patent/CN1069312C/zh not_active Expired - Fee Related
- 1996-10-31 AR ARP960104995A patent/AR004253A1/es unknown
- 1996-10-31 US US08/740,634 patent/US5708034A/en not_active Expired - Lifetime
- 1996-10-31 RU RU96121572/04A patent/RU2180658C2/ru not_active IP Right Cessation
- 1996-10-31 SK SK1418-96A patent/SK281766B6/sk unknown
- 1996-11-01 AU AU70608/96A patent/AU707256B2/en not_active Ceased
- 1996-11-01 TR TR96/00873A patent/TR199600873A2/xx unknown
- 1996-11-01 NO NO964639A patent/NO306550B1/no not_active IP Right Cessation
- 1996-11-01 ZA ZA969211A patent/ZA969211B/xx unknown
- 1996-11-01 NZ NZ299682A patent/NZ299682A/en unknown
- 1996-11-01 HU HU9603023A patent/HUP9603023A3/hu unknown
- 1996-11-01 KR KR1019960051506A patent/KR970025611A/ko not_active Ceased
- 1996-11-01 JP JP29139696A patent/JP3924028B2/ja not_active Expired - Fee Related
- 1996-11-01 MY MYPI96004552A patent/MY132862A/en unknown
- 1996-11-01 MX MX9605317A patent/MX9605317A/es not_active IP Right Cessation
- 1996-11-03 IL IL11955296A patent/IL119552A/xx not_active IP Right Cessation
- 1996-11-04 BR BR9605417A patent/BR9605417A/pt not_active Application Discontinuation
2000
- 2000-02-18 GR GR20000400387T patent/GR3032689T3/el not_active IP Right Cessation

Also Published As

Publication number	Publication date
HU9603023D0 (en)	1996-12-30
GR3032689T3 (en)	2000-06-30
PT771788E (pt)	2000-05-31
HUP9603023A2 (hu)	1998-01-28
CA2189221A1 (en)	1997-05-04
JPH09169723A (ja)	1997-06-30
EP0771788B1 (de)	2000-01-12
NO964639L (no)	1997-05-05
HUP9603023A3 (en)	1998-12-28
CN1069312C (zh)	2001-08-08
SK141896A3 (en)	1997-06-04
ATE188688T1 (de)	2000-01-15
ZA969211B (en)	1997-05-03
ES2143122T3 (es)	2000-05-01
NO306550B1 (no)	1999-11-22
CZ290811B6 (cs)	2002-10-16
SK281766B6 (sk)	2001-07-10
DK0771788T3 (da)	2000-06-13
CZ318496A3 (en)	1997-05-14
EP0771788A2 (de)	1997-05-07
AR004253A1 (es)	1998-11-04
AU707256B2 (en)	1999-07-08
IL119552A0 (en)	1997-02-18
DE19540995A1 (de)	1997-05-07
SI0771788T1 (en)	2000-04-30
TR199600873A2 (tr)	1997-05-21
NZ299682A (en)	1997-07-27
DE59604165D1 (de)	2000-02-17
PL316440A1 (en)	1997-05-12
HRP960496B1 (en)	2000-12-31
IL119552A (en)	2000-09-28
JP3924028B2 (ja)	2007-06-06
PL184570B1 (pl)	2002-11-29
AU7060896A (en)	1997-05-08
CN1155538A (zh)	1997-07-30
TW352382B (en)	1999-02-11
US5708034A (en)	1998-01-13
CA2189221C (en)	2006-10-03
RU2180658C2 (ru)	2002-03-20
KR970025611A (ko)	1997-06-24
HRP960496A2 (en)	1998-02-28
NO964639D0 (no)	1996-11-01
MX9605317A (es)	1997-05-31
EP0771788A3 (de)	1997-09-03
MY132862A (en)	2007-10-31

Publication	Publication Date	Title
BR9605417A (pt)	1998-08-04	Sulfonimidamidas substituídas processos para a sua preparação seu emprego como medicamento ou diagnóstico bem como o medicamento contendo as mesmas
BR9703161A (pt)	1998-09-29	Cromanos substituídos por sulfonamida processos para a sua preparação seu emprego como medicamento ou diagnóstico bem como medicamento contendo os mesmos
NO905431L (no)	1991-06-19	Trykkapplikator for medikament.
DE3861517D1 (de)	1991-02-14	Blutdruckueberwacher.
DE69017387D1 (de)	1995-04-06	Verbesserungen für Blutentnahmegeräte.
BR9604294A (pt)	1998-05-26	Dispositivo para o tratamento de líquidos especialmente de sangue bem como a sua utilização
NL300077I1 (nl)	2002-03-01	Erythromycineverbindingen, werkwijze voor hun bereiding en hun toepassing als geneesmiddel.
DE68920109D1 (de)	1995-02-02	Arzneimittelpräparat für perkutane Absorption.
NO901158D0 (no)	1990-03-13	Blodtrykk-overvaakningskateter.
DE3876417D1 (de)	1993-01-14	Einmalfilter.
FI884448A7 (fi)	1989-04-08	Verenottoventtiili.
DE68905161D1 (de)	1993-04-08	Den blutcholesterinspiegel senkende arzneimittel.
FI884844L (fi)	1989-04-23	Sanitetsmedel.
FI893835L (fi)	1990-02-17	Laekemedel.
BR9603911A (pt)	1998-06-09	Benzoilguanidinas substituídas processo para a sua preparação seu emprego como medicamento ou diagnóstico bem como o medicamento contendo as mesmas
FI891245L (fi)	1989-03-16	Starka soetningsmedel.
NO163556C (no)	1990-06-20	Kobling, spesielt for medisinsk anvendelse.
BR9703338A (pt)	1998-08-18	2-Naftoil guanidinas substituídas processo para a sua preparaçao sua aplicaçao como medicamento ou diagnóstico bem como medicamento que as contêm
NO960364L (no)	1996-07-31	Basisk-substituerte benzolguanidiner, fremgangsmåte for fremstilling derav, deres anvendelse som medikament eller diagnostikum samt medikament inneholdende forbindelsen
BR9703440A (pt)	1998-09-29	Benzoilguadinas orto-substituídas processos para sua preparação seu emprego como medicamento ou diagnóstico bem como medicamento contendo as mesmas
TR199600118A2 (tr)	1996-10-21	Sübstitüe edilmis benzolsulfonil üreler ve tioüreler, bunlarin üretilmesine mahsus usul, ilac veya diyagnostik olarak kullanilmalari ve bunlari ihtiva eden ilac.
FI943853L (fi)	1995-02-25	Diasyylisubstituoidut guanidiinit, menetelmä niiden valmistamiseksi, niiden käyttö lääkeaineena tai diagnostisena aineena sekä niitä sisältävä lääkeaine
BR9800708A (pt)	1999-07-20	Cromans substituídos com sulfonamida processos para a sua preparação sua utilização como medicamento ou auxiliares de diagnóstico e medicamento compreendendo os mesmos
NO880274D0 (no)	1988-01-22	Medisinsk diagnoseanordning.
BR9703617A (pt)	1998-09-29	Benzoilguanidinas orto-substituídas processo para a sua preparação seu emprego como medicamento ou diagnóstico bem como medicamento contendo as mesmas

Legal Events

Date	Code	Title	Description
2005-09-27	B07A	Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
2006-02-21	B09B	Patent application refused [chapter 9.2 patent gazette]	Free format text: INDEFIRO O PRESENTE PEDIDO DE PATENTE COMO INVENCAO DE ACORDO COM O ART. 8O DA LPI.